↓ Skip to main content

Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization’s database

Overview of attention for article published in Frontiers in Pharmacology, October 2023
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
5 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization’s database
Published in
Frontiers in Pharmacology, October 2023
DOI 10.3389/fphar.2023.1278682
Pubmed ID
Authors

Rachel Prevost, Basile Chretien, Elise-Marie Minoc, Charles Dolladille, Angélique Da-Silva, Ahmad Nehme, Florence Joly, Véronique Lelong-Boulouard, Etienne Bastien

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 20%
Student > Postgraduate 1 20%
Unknown 3 60%
Readers by discipline Count As %
Nursing and Health Professions 1 20%
Unknown 4 80%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2023.
All research outputs
#22,086,626
of 24,647,023 outputs
Outputs from Frontiers in Pharmacology
#11,869
of 18,704 outputs
Outputs of similar age
#126,015
of 159,185 outputs
Outputs of similar age from Frontiers in Pharmacology
#113
of 349 outputs
Altmetric has tracked 24,647,023 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 18,704 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 159,185 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 349 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.